Simplex Trading’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-71,404
| Closed | -$3.33M | – | 9134 |
|
|
2025
Q3 | $3.08M | Sell |
71,404
-64,191
| -47% | -$2.51M | ﹤0.01% | 1904 |
|
|
2025
Q2 | $5.21M | Buy |
+135,595
| New | +$5.18M | ﹤0.01% | 1310 |
|
|
2025
Q1 | – | Sell |
-42,113
| Closed | -$1.54M | – | 8921 |
|
|
2024
Q4 | $1.42M | Buy |
+42,113
| New | +$1.52M | ﹤0.01% | 2514 |
|
|
2024
Q3 | – | Sell |
-61,149
| Closed | -$2.5M | – | 8912 |
|
|
2024
Q2 | $2.35M | Buy |
+61,149
| New | +$2.57M | ﹤0.01% | 2052 |
|
|
2024
Q1 | – | Sell |
-23,924
| Closed | -$987K | – | 9238 |
|
|
2023
Q4 | $886K | Sell |
23,924
-100,539
| -81% | -$3.61M | ﹤0.01% | 3109 |
|
|
2023
Q3 | $4.51M | Sell |
124,463
-26,816
| -18% | -$952K | ﹤0.01% | 1431 |
|
|
2023
Q2 | $5.39M | Sell |
151,279
-38,297
| -20% | -$1.37M | ﹤0.01% | 1268 |
|
|
2023
Q1 | $6.75M | Sell |
189,576
-95,562
| -34% | -$3.34M | 0.01% | 1110 |
|
|
2022
Q4 | $10M | Sell |
285,138
-112,980
| -28% | -$3.76M | 0.01% | 849 |
|
|
2022
Q3 | $11.7M | Buy |
398,118
+275,509
| +225% | +$10.4M | 0.01% | 731 |
|
|
2022
Q2 | $6.67M | Buy |
122,609
+33,930
| +38% | +$1.87M | 0.01% | 988 |
|
|
2022
Q1 | $4.83M | Buy |
88,679
+58,613
| +195% | +$3.18M | ﹤0.01% | 1273 |
|
|
2021
Q4 | $1.66M | Buy |
30,066
+28,800
| +2,275% | +$1.5M | ﹤0.01% | 2231 |
|
|
2021
Q3 | $63K | Hold |
1,266
| – | – | ﹤0.01% | 7236 |
|
|
2021
Q2 | $63K | Sell |
1,266
-55,730
| -98% | -$2.68M | ﹤0.01% | 7362 |
|
|
2021
Q1 | $2.54M | Sell |
56,996
-27,130
| -32% | -$1.23M | ﹤0.01% | 1368 |
|
|
2020
Q4 | $3.87M | Buy |
84,126
+52,768
| +168% | +$2.42M | 0.01% | 1181 |
|
|
2020
Q3 | $1.48M | Buy |
31,358
+10,463
| +50% | +$524K | ﹤0.01% | 1819 |
|
|
2020
Q2 | $1.06M | Buy |
+20,895
| New | +$1.07M | ﹤0.01% | 2098 |
|
|
2019
Q1 | – | Sell |
-7,872
| Closed | -$393K | – | 7365 |
|
|
2018
Q4 | $375K | Buy |
7,872
+7,712
| +4,820% | +$380K | ﹤0.01% | 2488 |
|
|
2018
Q3 | $8K | Buy |
+160
| New | +$8.13K | ﹤0.01% | 6524 |
|
|
2017
Q1 | – | Sell |
-19,855
| Closed | -$1.01M | – | 6373 |
|
|
2016
Q4 | $955K | Buy |
+19,855
| New | +$981K | 0.06% | 290 |
|
|
2016
Q2 | – | Sell |
-13,580
| Closed | -$715K | – | 6035 |
|
|
2016
Q1 | $688K | Sell |
13,580
-3,160
| -19% | -$157K | 0.05% | 322 |
|
|
2015
Q4 | $844K | Buy |
16,740
+11,154
| +200% | +$569K | 0.07% | 261 |
|
|
2015
Q3 | $268K | Sell |
5,586
-15,503
| -74% | -$807K | 0.02% | 748 |
|
|
2015
Q2 | $1.1M | Buy |
21,089
+17,435
| +477% | +$982K | 0.09% | 196 |
|
|
2015
Q1 | $210K | Sell |
3,654
-16,353
| -82% | -$938K | 0.02% | 703 |
|
|
2014
Q4 | $1.07M | Buy |
+20,007
| New | +$1.12M | 0.13% | 142 |
|
Other funds holding GSK
JEST
Simplex Trading's GSK Position: Q4 2025 in Review
Simplex Trading sold out of GSK (GSK) in Q4 2025, closing a stake of 71,404 shares — an estimated $3.33M sold.
Simplex Trading first reported a position in GSK in Q4 2014 and held it in 28 quarters. The position peaked at $11.7M in Q3 2022. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.
- Simplex Trading reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 71,404 GSK shares in Q4 2025, an estimated $3.33M.
- Simplex Trading first reported a position in GSK in Q4 2014 and held it in 28 quarters.
- Simplex Trading's GSK position peaked at $11.7M in Q3 2022.
- 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.